FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 393.0
(-0.57%)
INR 393.0
(-0.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.1 Billion INR | -36.34% |
| 2022 | 1.83 Billion INR | -15.82% |
| 2021 | 2.18 Billion INR | 6.38% |
| 2020 | 2.05 Billion INR | 4.23% |
| 2019 | 1.96 Billion INR | 21.36% |
| 2018 | 1.62 Billion INR | 8.29% |
| 2017 | 1.49 Billion INR | 76.64% |
| 2016 | 847.82 Million INR | 0.17% |
| 2015 | 846.41 Million INR | 57.98% |
| 2014 | 535.77 Million INR | 88.08% |
| 2013 | 284.87 Million INR | 241.23% |
| 2012 | 83.48 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 1.16 Billion INR | -36.43% |
| 2023 Q1 | 610.59 Million INR | -66.65% |
| 2023 Q2 | 1.16 Billion INR | 90.93% |
| 2023 Q4 | 1.1 Billion INR | 100.65% |
| 2023 Q3 | 550.42 Million INR | -52.79% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 2.04 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.83 Billion INR | 0.0% |
| 2022 FY | 1.83 Billion INR | -15.82% |
| 2021 FY | 2.18 Billion INR | 6.38% |
| 2021 Q4 | 2.18 Billion INR | 484.63% |
| 2021 Q1 | 363.67 Million INR | -82.27% |
| 2021 Q2 | 1.86 Billion INR | 412.78% |
| 2021 Q3 | 373.24 Million INR | -79.98% |
| 2020 Q4 | 2.05 Billion INR | 227.79% |
| 2020 FY | 2.05 Billion INR | 4.23% |
| 2020 Q1 | 331.09 Million INR | -84.63% |
| 2020 Q2 | 1.62 Billion INR | 390.41% |
| 2020 Q3 | 625.8 Million INR | -61.46% |
| 2019 Q3 | 993.81 Million INR | -12.84% |
| 2019 Q1 | 876.24 Million INR | -47.82% |
| 2019 FY | 1.96 Billion INR | 21.36% |
| 2019 Q2 | 1.14 Billion INR | 30.12% |
| 2019 Q4 | 2.15 Billion INR | 116.76% |
| 2018 Q4 | 1.67 Billion INR | 143.6% |
| 2018 FY | 1.62 Billion INR | 8.29% |
| 2018 Q3 | 689.35 Million INR | -42.79% |
| 2018 Q2 | 1.2 Billion INR | 257.35% |
| 2018 Q1 | 337.18 Million INR | -76.03% |
| 2017 Q2 | 786.11 Million INR | 2142.27% |
| 2017 Q3 | 65.73 Million INR | -91.64% |
| 2017 Q4 | 1.4 Billion INR | 2040.15% |
| 2017 FY | 1.49 Billion INR | 76.64% |
| 2017 Q1 | 35.05 Million INR | -95.88% |
| 2016 FY | 847.82 Million INR | 0.17% |
| 2016 Q4 | 850.32 Million INR | 540.97% |
| 2016 Q3 | 132.66 Million INR | -77.13% |
| 2016 Q2 | 580.15 Million INR | 0.0% |
| 2015 Q2 | 757.04 Million INR | 273.65% |
| 2015 Q1 | 202.6 Million INR | -62.18% |
| 2015 FY | 846.41 Million INR | 57.98% |
| 2015 Q4 | 840.09 Million INR | 552.17% |
| 2015 Q3 | 128.81 Million INR | -82.98% |
| 2014 Q2 | 83.76 Million INR | -79.05% |
| 2014 Q3 | 261.18 Million INR | 211.8% |
| 2014 Q1 | 399.91 Million INR | 40.38% |
| 2014 FY | 535.77 Million INR | 88.08% |
| 2014 Q4 | 535.77 Million INR | 105.13% |
| 2013 FY | 284.87 Million INR | 241.23% |
| 2013 Q3 | 276.75 Million INR | 202.74% |
| 2013 Q4 | 284.87 Million INR | 2.93% |
| 2013 Q2 | 91.41 Million INR | 0.0% |
| 2012 Q3 | 535.56 Million INR | 0.0% |
| 2012 FY | 83.48 Million INR | 0.0% |
| 2012 Q4 | 83.48 Million INR | -84.41% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 18.48% |
| Biocon Limited | 140.18 Billion INR | 99.212% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 232.914% |
| Concord Biotech Limited | -372.86 Million INR | 396.197% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 94.185% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 1818557.536% |
| Lyka Labs Limited | 527.01 Million INR | -109.563% |
| Panacea Biotec Limited | -1.18 Billion INR | 193.208% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | -4922.547% |
| Servoteach Industries Limited | 5016.00 INR | -22017882.456% |
| SMS Lifesciences India Limited | 992.31 Million INR | -11.298% |
| Supriya Lifescience Limited | -694.68 Million INR | 258.983% |
| Syngene International Limited | -83 Million INR | 1430.629% |
| TAKE Solutions Limited | 361.37 Million INR | -205.621% |
| Titan Biotech Limited | 54.62 Million INR | -1921.714% |
| Transgene Biotek Limited | 139.93 Million INR | -689.251% |
| Vanta Bioscience Limited | 607.93 Million INR | -81.669% |